About the Bayer “Grants4Apps Accelerator”
The “Grants4Apps (G4A) Accelerator” is part of Bayer’s open innovation initiatives and aims at creating an environment in which to advance digital innovation in healthcare. The “G4A Accelerator” program was established in 2014 and offers dedicated office space for five digital health startups with concepts for innovative technology solutions to healthcare problems at the premises of Bayer in Berlin. The program wants to support the digital health startups in further advancing their projects and business models. Each startup receives up to 50,000 Euro as financial support and can stay in the “Grants4Apps Accelerator” premises for about 100 days. During this time, Bayer offers experienced managers as coaches to the startups, in addition to intensive mentoring by external entrepreneurs.
Learn more on
xbird is a medical artificial intelligence company who will save 1 million lives by 2020 by predicting critical health events. The company uses data from smartphones and wearables to recognize critical health patterns and to prevent hypoglycemia for diabetes patients. xbird uses passive tracking of existing user data with most advanced machine learning technologies for data collection and analysis. The company is built on newest research findings build by a core team of data scientists, medical doctors and serial entrepreneurs from Berlin and the Silicon Valley.